期刊文献+

乳腺浸润性导管癌c-erbB-2的表达与淋巴结转移和肿瘤细胞分裂能力的关系 被引量:1

Expression of C-erbB-2 and its related with lymph node metastasis,cell karyokinesis in breast infiltrating ductal carcinoma
下载PDF
导出
摘要 目的探讨乳腺浸润性导管癌中c-erbB-2与肿瘤生物学特性的关系。方法应用免疫组化SP方法对检测乳腺浸润性导管癌c-erbB-2的表达情况极其淋巴结转移和癌细胞分裂能力的相关性。结果c-erbB-2阳性表达主要分布在肿瘤细胞的胞膜上;随着c-erbB-2表达强度的降低,肿瘤淋巴结转移率呈减少的趋势;肿瘤组织中细胞的核分裂数目随着c-erbB-2的表达强度增加而增多。结论c-erbB-2是乳腺癌细胞增殖、转移能力和预后判定的参考指标。 Objective Toinvestigate the relatioship of expression of c-erbB-2 and biological behayiors in breast infiltrating ductal earcinoma. Methods lmmunolust-ochemical SP method was used to detccted c-erbB-2 expression, lymph ncde metastasis and karyokinesis of earcer cells in breast infiltrting ductal carcinoma. Results The c-erbB-2 positive staining was on the turmor cell membrane.The rate of lymph node metastasis showed to decrease with the weakness of c-erbB-2 expression. At same time, the karyokinesis of tumor cell has the trend to increase with higher expression of c-erbB-2 .Conclusion c-erbB-2 play the important role in assessing the lymph onde metastasis, karyokinesis and prongosis in breasi cancer.
出处 《中国实验诊断学》 2005年第5期708-710,共3页 Chinese Journal of Laboratory Diagnosis
基金 教育部高校优秀青年教师奖励计划
关键词 C-ERBB-2 乳腺浸润性导管癌 淋巴结转移 核分裂 c-erbB-2 irnnunobisto chertuistry lymph node metastasis karyokinesis
  • 相关文献

参考文献8

二级参考文献39

  • 1叶锋,黄冰.乳腺肿瘤中c—erbB—2癌基因产物的表达及意义[J].中华病理学杂志,1993,22(2):104-106. 被引量:25
  • 2吴名耀,郑瑞明,李乔山.乳腺癌癌基因产物和激素受体的免疫组化研究[J].临床与实验病理学杂志,1996,12(2):183-184. 被引量:10
  • 3姜琨,童坦君.原癌基因c-erbB-2研究进展[J].中华医学杂志,1996,76(2):158-160. 被引量:22
  • 4Bianco AR,De laurentiis M,Carlomagno C,et al. HER2overexpression predicts adjuvant tamoxifen failure for early breast cancer: Complete data at 20 years of the naples GUN randomized trial. Proc Am Soc Clin Oncol,2000,19: 75a .
  • 5Pietras RJ,Poen JC,Gallardo D, et al. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cellsoverexpressing this oncogene. Cancer Res, 1999,59:1347 ~1355.
  • 6Wiles DW, Harris WH,Gillett CE,et al. Effect of c-erbB (2) and estrogn receptor status on survival of woman with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil. Int J Cancer,1999,84: 354~359.
  • 7Klapper LN, Glathe S, Vaisman N, et al. The erbB-2/ HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors. Proc Natl Acad Sci USA, 1999,96:4995~5000.
  • 8Konecoy G,Pegram MD, Beryt M,et al. Therapeutic advantage of chemotherapy drugs in combination with herceptin against human breast cancer cells with HER-2/neu overexpression. Breast Cancer Res Treat. 1999,57:114.
  • 9Wong WL, Bajamonde A, Nelson B, et al. Baseline serum HER2 levels in the pivotal herceptin breast cancer trials:a comparison of 2 ELISA methods. Proc AM Soc Clin Oncol, 2000,19: 77a.
  • 10Bundred NJ. Prognostic and predictive factors in breast cancer. Cancer Treat Rev, 2001,27(3): 137- 142.

共引文献7

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部